Search
for

    Sort by

    Research

    120-150 / 1000+ results
      New Drugs: Iobenguane Sulfate

      research New drugs: Iobenguane sulfate

      October 2004 in “Australian Prescriber”
      This discussion reviews the lack of long-term clinical studies on metformin's cardiovascular benefits in women with polycystic ovary syndrome, advocating for lifestyle changes to improve insulin sensitivity.
      New Proprietary Brands: Cephalexin

      research NEW PROPRIETARY BRANDS: Cephalexin

      October 2004 in “Australian Prescriber”
      This article discusses the management of long-term cardiovascular risks in women with polycystic ovary syndrome and suggests that lifestyle changes may be more effective than metformin in reducing the incidence of type 2 diabetes.
      New Drugs: Agalsidase Beta

      research New drugs: Agalsidase beta

      October 2004 in “Australian Prescriber”
      This article discusses the long-term cardiovascular risks associated with polycystic ovary syndrome and highlights the greater effectiveness of lifestyle changes compared to metformin in preventing type 2 diabetes, but provides no new clinical outcomes.
      New Formulations: Sodium Cromoglycate

      research NEW FORMULATIONS: Sodium cromoglycate

      October 2004 in “Australian Prescriber”
      This review discusses the management of long-term risks in women with polycystic ovary syndrome, recommending lifestyle changes to improve insulin sensitivity over relying solely on metformin, and reports no new clinical results.
      New Proprietary Brands: Cefaclor Monohydrate

      research NEW PROPRIETARY BRANDS: Cefaclor monohydrate

      October 2004 in “Australian Prescriber”
      This article discusses the role of insulin resistance in cardiovascular risk and suggests that lifestyle changes may be more beneficial than metformin in managing polycystic ovary syndrome; it reports no new clinical results.
      New Formulations: Glatiramer Acetate

      research NEW FORMULATIONS: Glatiramer acetate

      October 2004 in “Australian Prescriber”
      This abstract reviews the management of polycystic ovary syndrome and highlights the potential benefits of lifestyle changes over metformin in reducing type 2 diabetes risk, yet reports no new clinical outcomes.
      New Drugs: Agalsidase Alfa

      research New drugs: Agalsidase alfa

      October 2004 in “Australian Prescriber”
      This review discusses the lack of long-term clinical studies on metformin's cardiovascular benefits in women with polycystic ovary syndrome, highlighting lifestyle changes as a crucial management strategy for reducing associated risks.
      Skin Diseases Associated With COVID-19: A Narrative Review

      research Skin Diseases Associated With COVID-19: A Narrative Review

      4 citations , April 2023 in “Cutis”
      This review examines various skin conditions associated with the COVID-19 pandemic, covering virus-related dermatoses and cutaneous side effects from treatments and vaccines, but reports no clinical results.
      Photobiomodulation in Cells' Repair

      research Photobiomodulation in Cells’ Repair

      1 citations , July 2020 in “Dermatology”
      This review discusses the mechanisms, applications, and research evidence of photobiomodulation, highlighting its efficacy, safety, and potential for standardized evaluation methods, but reports no new clinical results.
      Comprehensive Overview of Polycystic Ovary Syndrome

      research Polycystic ovary syndrome

      883 citations , August 2016 in “Nature Reviews Disease Primers”
      This review discusses the current understanding of polycystic ovary syndrome, focusing on its epidemiology, pathophysiology, diagnosis, management, and future research directions, but reports no new clinical results.
      Plants Used in Cosmetics

      research Plants used in cosmetics

      434 citations , October 2003 in “PTR. Phytotherapy research/Phytotherapy research”
      This review discusses the use of natural products in cosmetic preparations for skin and hair care, but reports no new research results.
      Polycystic Ovary Syndrome and Cardiovascular Disease: A Premature Association?

      research Polycystic Ovary Syndrome and Cardiovascular Disease: A Premature Association?

      418 citations , June 2003 in “Endocrine Reviews”
      This review discusses the relationship between polycystic ovary syndrome and cardiovascular risk, noting a possible adverse impact on risk profiles and subclinical atherosclerosis but no clear increase in premenopausal cardiovascular events; it presents no new clinical results.
      Colon Cancer Stem Cells: Promise of Targeted Therapy

      research Colon Cancer Stem Cells: Promise of Targeted Therapy

      411 citations , April 2010 in “Gastroenterology”
      This review explores various theories of colorectal cancer stem cell biology and highlights the need for better identification and targeting of these cells to advance treatment strategies, but reports no new clinical findings.
      Obesity and the Skin: Skin Physiology and Skin Manifestations of Obesity

      research Obesity and the skin: Skin physiology and skin manifestations of obesity

      405 citations , May 2007 in “Journal of The American Academy of Dermatology”
      This review discusses the profound impact of obesity on skin physiology and dermatologic conditions and reports no new experimental results, recommending awareness and treatment strategy development for obesity-associated dermatoses.
      Treatment of Hair Loss

      research Treatment of Hair Loss

      370 citations , September 1999 in “The New England Journal of Medicine”
      This article discusses the treatment of androgenetic alopecia and alopecia areata with finasteride and minoxidil but reports no new clinical results.
      The Pathophysiology of Polycystic Ovary Syndrome

      research The pathophysiology of polycystic ovary syndrome

      249 citations , November 2003 in “Clinical endocrinology”
      This review discusses the complex etiology of polycystic ovary syndrome (PCOS), highlighting its association with insulin resistance and hyperandrogenism, but reports no clinical findings; the authors suggest further investigation of the pathophysiological mechanisms.